Apeiron Investment Group Ltd.'s Net Worth
$46.7 Million
Who is Apeiron Investment Group Ltd.?
Apeiron Investment Group Ltd. has an estimated net worth of $46.7 Million. This is based on reported shares across multiple companies, which include Alto Neuroscience, Inc., ATAI Life Sciences N.V., and Sensei Biotherapeutics, Inc..
SEC CIK
Apeiron Investment Group Ltd.'s CIK is 0001845711
Past Insider Trading and Trends
2022 was Apeiron Investment Group Ltd.'s most active year for acquiring shares with 15 total transactions. Apeiron Investment Group Ltd.'s most active month to acquire stocks was the month of March. 2023 was Apeiron Investment Group Ltd.'s most active year for disposing of shares, totalling 2 transactions. Apeiron Investment Group Ltd.'s most active month to dispose stocks was the month of May. 2021 saw Apeiron Investment Group Ltd. paying a total of $10,500,000.00 for 700,000 shares, this is the most they've acquired in one year. In 2023 Apeiron Investment Group Ltd. cashed out on 3,441,661 shares for a total of $5,437,824.38, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alto Neuroscience, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 926.54K |
—
|
—
| 926.54K |
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ATAI Life Sciences N.V. (ATAI) Snapshot price: $1.6725
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
| +3.93% | 1.21M |
$1.32 | $1,600,443.45 | 32.09M |
Mar 29
| |||
Form 4
| +9.22% | 136.39K |
$5.02 | $684,553.43 | 1.61M |
Apr 20 - Apr 21
| |||
Form 4
| +3.25% | 56.6K |
$4.46 | $252,490.15 | 1.8M |
Apr 28 - Apr 29
| |||
Form 4
| +3.94% | 66.01K |
$4.67 | $308,567.05 | 1.74M |
Apr 26 - Apr 27
| |||
Form 4
| +3.83% | 61.78K |
$4.82 | $297,804.68 | 1.68M |
Apr 22 - Apr 25
| |||
Form 4
| +8.80% | 119.64K |
$5.12 | $612,395.41 | 1.48M |
Apr 18 - Apr 19
| |||
Form 4
| +0.37% | 4.97K |
$5.19 | $25,778.73 | 1.36M |
Apr 14
| |||
Form 4
| +4.25% | 55.2K |
$4.88 | $269,560.07 | 1.35M |
Apr 12
| |||
Form 4
| +9.40% | 111.61K |
$4.82 | $538,194.10 | 1.3M |
Apr 8 - Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +3.59% | 700K |
$15.00 | $10,500,000.00 | 20.19M |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sensei Biotherapeutics, Inc. (SNSE) Snapshot price: $0.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.44M |
$1.58 | -$5,437,824.38 |
0
|
Jun 1
| |||
Form 4
| +0.09% | 2.2K |
$1.61 | $3,539.03 | 2.49M |
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||